CDC20 maintains tumor initiating cells
Open Access
- 28 April 2015
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 6 (15) , 13241-13254
Abstract
CDC20 maintains tumor initiating cells CDC20 maintains tumor initiating cellsKeywords
This publication has 66 references indexed in Scilit:
- Integrative analysis of 111 reference human epigenomesNature, 2015
- Cdc20 and securin overexpression predict short-term breast cancer survivalBritish Journal of Cancer, 2014
- Survivin promoter-regulated oncolytic adenovirus with Hsp70 gene exerts effective antitumor efficacy in gastric cancer immunotherapyOncotarget, 2013
- Cdc20 turnover rate: A key determinant in cancer patient response to anti-mitotic therapies?BioEssays, 2013
- The Accuracy of Survival Time Prediction for Patients with Glioma Is Improved by Measuring Mitotic Spindle Checkpoint Gene ExpressionPLOS ONE, 2011
- Pharmacologic Inhibition of the Anaphase-Promoting Complex Induces A Spindle Checkpoint-Dependent Mitotic Arrest in the Absence of Spindle DamageCancer Cell, 2010
- SOX2 Silencing in Glioblastoma Tumor-Initiating Cells Causes Stop of Proliferation and Loss of TumorigenicityStem Cells, 2009
- Cancer Stem Cell Analysis and Clinical Outcome in Patients with Glioblastoma MultiformeClinical Cancer Research, 2008
- Targeting Cancer Stem Cells through L1CAM Suppresses Glioma GrowthCancer Research, 2008
- A self-renewing multipotential stem cell in embryonic rat cerebral cortexNature, 1994